[J.G.Chemicals Ltd ] CMP 409
Date:26-12-2024
Time: 12:12PM
CMP: 409
Report by : Mujadid Saad
Evaluation of J.G. Chemicals Ltd for Long-Term Investment
1. Financial Health
• Revenue Growth: Revenue grew from ₹398 Cr (Mar 2020) to ₹757 Cr (TTM), with a notable dip in FY 2024 (₹666 Cr). TTM shows recovery.
• Net Profit Margin: Improved from ~3.5% (Mar 2020) to ~7.5% (Mar 2024), reflecting better operational efficiency.
• Debt-to-Equity Ratio: Reduced to 0.03, indicating financial prudence.
• ROE: Declined from 20% (3-year avg.) to 10% last year, suggesting recent inefficiencies.
• Free Cash Flow: Significant positive shift to ₹76 Cr (Mar 2024) from marginal levels earlier.
• EPS: Fluctuating, with recent growth to ₹14.65 (TTM). Dividend payout remains nil.
2. Market Position
• Market Share: Largest zinc oxide manufacturer in India with 30% share; global top 10 producer.
• Competitive Positioning: Leader in the sector, leveraging advanced French process technology.
• Customer Loyalty & Innovation: Stable but needs further emphasis on innovative applications for diversification.
3. Management and Governance
• Leadership Track Record: Stable leadership but lacking aggressive expansion strategies.
• Governance: No significant red flags, though dividend policy may signal management conservatism.
• Litigation/Ethical Concerns: No notable controversies observed.
4. Industry Trends
• Growth Outlook: Positive, driven by increased demand for zinc oxide in industrial and cosmetic applications.
• Emerging Trends: Limited focus on ESG initiatives and digital transformation, which are becoming critical in global markets.
• Macroeconomic Factors: Vulnerable to commodity price volatility, regulatory changes, and inflation.
5. Risk Analysis
• Market Volatility: Sensitive to zinc price fluctuations.
• Operational Inefficiencies: Decline in recent ROE and revenue suggests areas of improvement.
• Geopolitical Factors: Export reliance makes it prone to global trade dynamics and regulatory risks.
6. Valuation
• P/E Ratio: At 29.9, below industry average (34.6), indicating reasonable valuation.
• P/B Ratio: Higher than peers but supported by leadership position.
• Overall: Stock appears fairly valued with potential for growth.
7. Performance Metrics
• ROI/ROA: Moderately improving; needs consistent growth.
• CAGR: Sales CAGR at ~15% (3 years); profit CAGR at ~12%.
• Achievements: Market leader with improved cash flow and reduced debt.
Investment Decision: Yes
Justification:
1. Market Leadership: Dominant position with 30% market share in India.
2. Financial Prudence: Strong debt reduction and improving cash flows.
3. Valuation: Fairly valued relative to peers with potential upside as industry demand grows.
4. Growth Prospects: Supported by recovery trends in revenue and net profit.
Recommendations for Further Due Diligence:
• Analyze customer concentration risks and reliance on exports.
• Assess plans for diversification and ESG adoption.
• Monitor upcoming quarterly results for sustained recovery in financials.
Time: 12:12PM
CMP: 409
Report by : Mujadid Saad
Evaluation of J.G. Chemicals Ltd for Long-Term Investment
1. Financial Health
• Revenue Growth: Revenue grew from ₹398 Cr (Mar 2020) to ₹757 Cr (TTM), with a notable dip in FY 2024 (₹666 Cr). TTM shows recovery.
• Net Profit Margin: Improved from ~3.5% (Mar 2020) to ~7.5% (Mar 2024), reflecting better operational efficiency.
• Debt-to-Equity Ratio: Reduced to 0.03, indicating financial prudence.
• ROE: Declined from 20% (3-year avg.) to 10% last year, suggesting recent inefficiencies.
• Free Cash Flow: Significant positive shift to ₹76 Cr (Mar 2024) from marginal levels earlier.
• EPS: Fluctuating, with recent growth to ₹14.65 (TTM). Dividend payout remains nil.
2. Market Position
• Market Share: Largest zinc oxide manufacturer in India with 30% share; global top 10 producer.
• Competitive Positioning: Leader in the sector, leveraging advanced French process technology.
• Customer Loyalty & Innovation: Stable but needs further emphasis on innovative applications for diversification.
3. Management and Governance
• Leadership Track Record: Stable leadership but lacking aggressive expansion strategies.
• Governance: No significant red flags, though dividend policy may signal management conservatism.
• Litigation/Ethical Concerns: No notable controversies observed.
4. Industry Trends
• Growth Outlook: Positive, driven by increased demand for zinc oxide in industrial and cosmetic applications.
• Emerging Trends: Limited focus on ESG initiatives and digital transformation, which are becoming critical in global markets.
• Macroeconomic Factors: Vulnerable to commodity price volatility, regulatory changes, and inflation.
5. Risk Analysis
• Market Volatility: Sensitive to zinc price fluctuations.
• Operational Inefficiencies: Decline in recent ROE and revenue suggests areas of improvement.
• Geopolitical Factors: Export reliance makes it prone to global trade dynamics and regulatory risks.
6. Valuation
• P/E Ratio: At 29.9, below industry average (34.6), indicating reasonable valuation.
• P/B Ratio: Higher than peers but supported by leadership position.
• Overall: Stock appears fairly valued with potential for growth.
7. Performance Metrics
• ROI/ROA: Moderately improving; needs consistent growth.
• CAGR: Sales CAGR at ~15% (3 years); profit CAGR at ~12%.
• Achievements: Market leader with improved cash flow and reduced debt.
Investment Decision: Yes
Justification:
1. Market Leadership: Dominant position with 30% market share in India.
2. Financial Prudence: Strong debt reduction and improving cash flows.
3. Valuation: Fairly valued relative to peers with potential upside as industry demand grows.
4. Growth Prospects: Supported by recovery trends in revenue and net profit.
Recommendations for Further Due Diligence:
• Analyze customer concentration risks and reliance on exports.
• Assess plans for diversification and ESG adoption.
• Monitor upcoming quarterly results for sustained recovery in financials.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.